Analysis and comparison of the trends in burden of atrial fibrillation/atrial flutter in China and worldwide from 1990 to 2021 and predictions to 2036 of China

Figures

• 

  Figure 1. Aged-specific number and age-standardized prevalence and incidence rates of AF/AFL in China. (A) Aged-specific prevalence number. (B) Age-standardized prevalence rate. (C) Aged-specific incidence number. (D) Age-standardized incidence rate.

• 

  Figure 2. Aged-specific number and age-standardized mortality and DALYs rates of AF/AFL in China. (A) Aged-specific mortality number. (B) Age-standardized mortality rate. (C) Aged-specific DALYs number. (D) Age-standardized DALYs rate.

• 

  Figure 3. Global trends in the all-age cases and age-standardized prevalence and incidence rates of AF/AFL by sex from 1990 to 2021. (A) Prevalence number and rate. (B) Incidence number and rate. (C) Mortality number and rate. (D) DALYs number and rate.

• 

  Figure 4. Trends of China in the all-age cases and age-standardized prevalence and incidence rates of AF/AFL by sex from 1990 to 2021. (A) Prevalence number and rate. (B) Incidence number and rate. (C) Mortality number and rate. (D) DALYs number and rate.

• 

  Figure 5. Joinpoint regression analysis of the sex-specific age-standardized incidence rate for AF/AFL worldwide from 1990 to 2021. (A) Age-standardized incidence rate for both. (B) Age-standardized incidence rate for males. (C) Age-standardized incidence rate for females.

• 

  Figure 6. Joinpoint regression analysis of the sex-specific age-standardized incidence rate for AF/AFL in China from 1990 to 2021. (A) Age-standardized incidence rate for both. (B) Age-standardized incidence rate for males. (C) Age-standardized incidence rate for females.

• 

  Figure 7. Joinpoint regression analysis of the sex-specific age-standardized mortality rate for AF/AFL worldwide from 1990 to 2021. (A) Age-standardized mortality rate for both. (B) Age-standardized mortality rate for males in worldwide. (C) Age-standardized mortality rate for females in worldwide.

• 

  Figure 8. Joinpoint regression analysis of the sex-specific age-standardized mortality rate for AF/AFL in China 1990 to 2021. (A) Age-standardized mortality rate for both. (B) Age-standardized mortality rate for males. (C) Age-standardized mortality rate for females.

• 

  Figure 9. Incidence and mortality rates of AF/AFL in China. (A) The age-specific incidence rates of AF/AFL according to time periods; each line connects the age-specific mortality for a 5-year period. (B) The age-specific incidence rates of AF/AFL according to birth cohorts; each line connects the age-specific mortality for a 5-year cohort. (C) The period-specific incidence rates of AF/AFL according to age groups; each line connects the birth cohort-specific mortality for a 5-year age group. (D) The birth cohort-specific incidence rates of AF/AFL according to age groups; each line connects the birth cohort-specific mortality for a 5-year age group. (E) The age-specific mortality rates of AF/AFL according to time periods; each line connects the age-specific mortality for a 5-year period. (F) The age-specific mortality rates of AF/AFL according to birth cohorts; each line connects the age-specific mortality for a 5-year cohort. (G) The period-specific mortality rates of AF/AFL according to age groups; each line connects the birth cohort-specific mortality for a 5-year age group. (H) The birth cohort-specific mortality rates of AF/AFL according to age groups; each line connects the birth…

• 

  Figure 10. Changes in AF/AFL incidence (A) and mortality (B) according to population growth, aging, and epidemiological change from 1990 to 2021 at the China level and by gender. The black dot represents the overall value of change contributed by all 3 components.

• 

  Figure 11. Health inequality regression curves (A) and concentration (B) for the DALYs of AF/AFL from 1990 to 2021 across the world.

• 

  Figure 12. Trends of age-standardized incidence rate (ASIR) from 2021 to 2036 in females (A) and males (B) predicted by Bayesian age-period-cohort (BAPC) models.